奧聯電子(300585.SZ):2019年淨利預降43.94%-48.43%
格隆匯1月22日丨奧聯電子(300585.SZ)披露2019年度業績預告,公司預計2019年1-12月歸屬於上市公司股東的淨利潤為2300萬元—2500萬元,同比下降43.94%-48.43%。
報告期內,歸屬於上市公司股東淨利潤下降的主要原因:①2018年股權激勵計劃提前終止,導致管理費用增加589萬元;②研發投入加大,研發費用增加531萬元;③銀行貸款金額增加,財務費用增加487萬元;④售後三包服務費用增加,導致銷售費用增加736萬元;⑤部分應收賬款無法收回,壞賬損失增加617萬元。
預計2019年非經常性損益對淨利潤影響為527萬元,去年同期影響金額為418萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.